 |
Articles: Pharmacology/kinetics |
Prior Articles
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
The Lancet, 07/20/09
Are Physically Active Individuals Taking Statins at Increased Risk for Myopathy?
American Journal of Lifestyle Medicine, 07/17/09
Revew Article
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily
Diabetic Medicine, 07/17/09 Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency
Therapeutics and Clinical Risk Management, 07/17/09
Free full text
The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective study
Diabetic Medicine, 07/16/09 Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes
Diabetic Medicine, 07/16/09 Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
International Journal of Clinical Practice, 07/16/09 Hyperthyroidism during pregnancy
Canadian Family Physician, 07/15/09
Free full text
Renal effects of aliskiren compared to and in combination with irbesartan in patients with type 2 diabetes, hypertension and albuminuria
Diabetes Care, 07/15/09 Insulin-Based versus Triple Oral Therapy for Newly-Diagnosed Type 2 Diabetes: Which is Better
Diabetes Care, 07/15/09 The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX
Osteoporosis International, 07/15/09 Can we prevent diabetic birth defects with micronutrients
Diabetes, Obesity and Metabolism, 07/14/09 Long-term effects of weight-reducing drugs in hypertensive patients
Cochrane Reviews, 07/14/09 The role of pioglitazone in modifying the atherogenic lipoprotein profile
Diabetes, Obesity and Metabolism, 07/14/09 Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes
Diabetes, Obesity and Metabolism, 07/14/09 Predicting steady-state HbA1c responses to sitagliptin in patients with type 2 diabetes mellitus
Diabetes, Obesity and Metabolism, 07/14/09 Pioglitazone decreases postprandial accumulation of remnant lipoproteins in insulin-resistant smokers
Diabetes, Obesity and Metabolism, 07/14/09 Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients
Diabetes, Obesity and Metabolism, 07/14/09 Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial
Diabetes, Obesity and Metabolism, 07/14/09 The new rosiglitazone story: Its place today in Type 2 diabetes management
Primary Care Diabetes, 07/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes
more...
|
250 Available Pages
|
|
